Clinical Trial Update: A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine [NA]

View source ↗

Summary

A prospective, randomized, open-label trial comparing two oral doses of betaine in participants with non-alcoholic fatty liver disease and non-insulin-dependent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Betaine (betaine (trimethylglycine))

Snippet

Sponsor: Southern California Institute for Research and Education | Conditions: Non-Alcoholic Fatty Liver Disease, Non Insulin Dependent Diabetes | NA | Status: RECRUITING